Medicine PharmaceuticalsAntineoplastic Agent
Our lead compounds exhibited potency against various targets that are essential for tumor cell proliferation. Animal models study data show that they are at least equivalent to, and in most cases superior to, competing clinical & marketed molecules.
Our primary research efforts are centered on cancer therapies. Using highly effective structural approaches, we have developed 5 pre-clinical oncology candidates.